Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Roberto Dal Negro"'
Autor:
Roberto Dal Negro
Publikováno v:
International Journal of COPD, Vol 2008, Iss Issue 1, Pp 1-10 (2008)
Roberto Dal NegroLung Dept., Orlandi General Hospital, Bussolengo, Verona ItalyAbstract: Attention to COPD is increasing worldwide because its high prevalence, morbidity, and mortality present a challenging problem for all healthcare systems. The bur
Externí odkaz:
https://doaj.org/article/8fbbc117958c417f91307e2b5c51be62
Autor:
Louis-Philippe Boulet, Robert L Cowie, Roberto Dal Negro, Wade Brett, Milton Gold, Agostinho Marques, William S Thorburn, Nate M Stepner, Reid Bobson
Publikováno v:
Canadian Respiratory Journal, Vol 7, Iss 3, Pp 239-247 (2000)
OBJECTIVES: Two 12-week, randomized, double-blind, parallel-group studies were performed to compare the efficacy and safety of once- and twice-daily dosing of fluticasone propionate (FP) in the treatment of mild to moderate asthma, considered to requ
Externí odkaz:
https://doaj.org/article/fa2bc665c4114d7c865ad9555ca4ff3a
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 5 (2011)
Background: In Italy, chronic obstructive pulmonary disease (COPD) has progressively received increasing attention in the last decade, and its impact has been investigated extensively in both clinical and pharmacoeconomic terms. Methods: In 2004, the
Externí odkaz:
https://doaj.org/article/bb9e47f1adef43ea9fe90dd92480a631
Autor:
Roberto Dal Negro, Maria Visconti, Fiorenza Trevisan, Stefano Bertacco, Claudio Micheletto, Silvia Tognella
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 2 (2008)
Background: Oxidative stress is presumed to impair β-adenoceptor function and airway patency. Erdosteine (E), a mucomodulatory compound, has shown important antioxidant properties. Methods: The objective was to assess the effect of antioxidant inter
Externí odkaz:
https://doaj.org/article/2e5ad64b35844946b19f12cac51c4e24
Publikováno v:
Current Therapeutic Research. 62:372-385
Background: The therapeutic strategy for antibiotic treatment of community-acquired pneumonia (CAP) and assessments of the efficacy of such treatments are usually based on microbiologic, clinical, and chest radiographic findings. However, all these t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d35ec97ba9b2055f254db13265a8abd
https://doi.org/10.1016/s0011-393x(01)89002-0
https://doi.org/10.1016/s0011-393x(01)89002-0
Bronchial asthma is a multifactorial disease. Cooperation between pneumologists, physiologists, immunologists, pharmacologist and pediatricians is frequently needed for the complete investigation of an asthma case. This means that a physician in gene
Autor:
Roberto Dal Negro
Publikováno v:
Therapeutic advances in cardiovascular disease. 3(4)
The pharmacological control of arterial hypertension is a very frequent issue in clinical practice and some critical aspects can arise in particular circumstances and with particular molecules. In the case of hypertensive subjects with respiratory co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8e7c32fadec7a5d0d2b0eefbe2f047
https://pubmed.ncbi.nlm.nih.gov/19638367
https://pubmed.ncbi.nlm.nih.gov/19638367
Autor:
Roberto Dal Negro, Peter Piskorz, Xavier Badia, Magda Guilera, Vasilisa Sazonov Kocevar, Roberto Vives
Publikováno v:
PharmacoEconomics. 25(8)
To evaluate the healthcare resource use and costs associated with adding montelukast to therapy in patients with mild to moderate persistent asthma and co-morbid seasonal allergic rhinitis whose asthma is inadequately controlled by their current asth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3cbfef27a041f8658531137d794b734
https://pubmed.ncbi.nlm.nih.gov/17640108
https://pubmed.ncbi.nlm.nih.gov/17640108
Autor:
Agostinho Marques, Louis-Philippe Boulet, Milton Gold, Robert L. Cowie, William S Thorburn, Nate Stepner, Roberto Dal Negro, Reid Robson, Wade Brett
Publikováno v:
Canadian Respiratory Journal, Vol 7, Iss 3, Pp 239-247 (2000)
OBJECTIVES:Two 12-week, randomized, double-blind, parallel-group studies were performed to compare the efficacy and safety of once- and twice-daily dosing of fluticasone propionate (FP) in the treatment of mild to moderate asthma, considered to requi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::256ca57240096d91b551061259091119
https://pubmed.ncbi.nlm.nih.gov/10903487
https://pubmed.ncbi.nlm.nih.gov/10903487
Publikováno v:
Methods in Asthmology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c07a27e84b5b4109113cc43cfa5269e
https://doi.org/10.1007/978-88-470-2263-8
https://doi.org/10.1007/978-88-470-2263-8